Academic literature on the topic 'Assisted Reproductive Technology'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Assisted Reproductive Technology.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Assisted Reproductive Technology"
Deep, JP. "Assisted Reproductive Technology." Journal of Chitwan Medical College 4, no. 1 (July 30, 2014): 1–10. http://dx.doi.org/10.3126/jcmc.v4i1.10840.
Full textSilva, Shana Ginar da, Andréa Dâmaso Bertoldi, Mariângela Freitas da Silveira, Marlos Rodrigues Domingues, Kelly R. Evenson, and Iná Silva dos Santos. "Assisted reproductive technology." Revista de Saúde Pública 53 (January 30, 2019): 13. http://dx.doi.org/10.11606/s1518-8787.2019053000737.
Full textYablonsky, Terri. "Assisted Reproductive Technology." Laboratory Medicine 27, no. 8 (August 1, 1996): 524–31. http://dx.doi.org/10.1093/labmed/27.8.524.
Full textTanbo, Tom, and Thomas Åbyholm. "Assisted reproductive technology." Current Opinion in Obstetrics and Gynecology 3, no. 5 (October 1991): 649–55. http://dx.doi.org/10.1097/00001703-199110000-00004.
Full textWatts, Robin. "Assisted reproductive technology." Collegian 4, no. 1 (January 1997): 12. http://dx.doi.org/10.1016/s1322-7696(08)60200-0.
Full textAbe, Takashi, Ryoko Tomiyama, Tomoko Ichikawa, Katsuya Mine, Shigeo Akira, and Toshiyuki Takeshita. "5. Assisted Reproductive Technology A Trend of Assisted Reproductive Technology (I)." Nihon Ika Daigaku Igakkai Zasshi 5, no. 4 (2009): 184–86. http://dx.doi.org/10.1272/manms.5.184.
Full textHogue, Carol J. Rowland. "Successful Assisted Reproductive Technology." Obstetrics & Gynecology 100, no. 5, Part 1 (November 2002): 1017–19. http://dx.doi.org/10.1097/00006250-200211000-00032.
Full textSimón, Carlos. "Personalized assisted reproductive technology." Fertility and Sterility 100, no. 4 (October 2013): 922–23. http://dx.doi.org/10.1016/j.fertnstert.2013.08.011.
Full textSacks, Preston C. "Assisted human reproductive technology." Reproductive Toxicology 6, no. 1 (January 1992): 109. http://dx.doi.org/10.1016/0890-6238(92)90028-r.
Full textSotoya Tsuyoshi. "Assisted Reproductive Technology and Bioethics." Journal of Next-Generation Humanities and Social Sciences ll, no. 14 (March 2018): 261–79. http://dx.doi.org/10.22538/jnghss.2018..14.261.
Full textDissertations / Theses on the topic "Assisted Reproductive Technology"
Morgan, Jonathan J. "State Regulation of Assisted Reproductive Technology." BYU ScholarsArchive, 2010. https://scholarsarchive.byu.edu/etd/2206.
Full textPangestu, Mulyoto 1963. "Drying biological material for use in assisted reproductive technology." Monash University, Institute of Reproduction and Development, 2002. http://arrow.monash.edu.au/hdl/1959.1/7879.
Full textChang, Jeani. "Relationship Between Assisted Reproductive Technology and Risk of Stillbirth." ScholarWorks, 2017. https://scholarworks.waldenu.edu/dissertations/4508.
Full textBatty, Lynne Patricia. "Assisted Reproductive Technology: The Aotearoa/New Zealand Policy Context: A thesis submitted in fulfilment of the requirements for the degree of Master of Arts in Sociology in the University of Canterbury." Thesis, University of Canterbury. Sociology, 2002. http://hdl.handle.net/10092/912.
Full textMcComiskey, Mark Henry. "Unrecognised healthcare consequences of children born following assisted reproductive technology." Thesis, Queen's University Belfast, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.675460.
Full textEllender, Stacey. "Assisted reproduction defining and evaluating the multiple outcomes of technologically advanced interventions /." online access from Digital Dissertation Consortium, 2005. http://libweb.cityu.edu.hk/cgi-bin/er/db/ddcdiss.pl?3193097.
Full textWilson, Poe Emma. "Vitrification of day 5/6 human morulas/blastocysts: A 10 year retrospective study in a private assisted reproductive techniques [ART] clinic." Thesis, Stellenbosch : Stellenbosch University, 2015. http://hdl.handle.net/10019.1/96876.
Full textENGLISH ABSTRACT: This study was designed to retrospectively evaluate the established embryo vitrification/warming programme currently implemented at Drs Aevitas Institute for Reproductive Medicine and to look at factors that might play a role in optimizing the pregnancy outcomes thereof. Vitrification is the achievement of a “state of suspended animation” wherein molecular translational motions are arrested without structural reorganization of the liquid. In embryo vitrification it involves placement of the embryo in a very small volume of vitrification medium that must be cooled at extremely high cooling rates. The vitrification medium contains cryoprotectants to prevent any cryoinjury from occurring to the embryo. This process was initially proposed to effectively manage supernumerary embryos, but it has also provided a viable method of reducing costs for additional embryo transfers as well as the reduction of the incidence of multiple births. Patients who are at risk of ovarian hyper stimulation syndrome (OHSS) can also have all of their embryos vitrified in advance to reduce the likelihood of adverse clinical symptoms if a pregnancy is established. Throughout the period in which vitrification has been in practice, there have been advances in technology as well as continual research being conducted to establish whether newly suggested techniques do, in fact, optimize the outcomes of vitrification. Focus has subsequently been applied to the carrier device used for vitrification, the day on which the embryos are vitrified and stored, as well as the number of embryos transferred in each respective cycle, all to ensure the most favourable outcome. This retrospective study confirmed the use of the Cryotop® as the most viable carrier device for successful survival and pregnancy outcomes. Transfer of day 5 vitrified embryos resulted in significantly higher pregnancy rates compared to day 6 vitrified embryos. Results also indicated that the number of embryos transferred does indeed have a significant effect on the pregnancy outcome and consequently we can possibly argue against the implementation of single embryo transfer in the vitrification programme. Investigation into the effect of female age, specifically oocyte age, on each of these categories indicated that reduced age can be associated with optimal outcomes; however this could not be proven statistically in this cohort of patients. To further look at optimization of the vitrification/warming programme, a Literature Survey was conducted to ascertain the results after Assisted Hatching in frozen/warmed human embryos. Assisted Hatching has been proposed as a solution to Zona Pellucida hardening, which has been found to occur during vitrification. The need for further studies and a meta-analysis of the literature is confidently proposed, as well as a Prospective Study to evaluate the effect of Laser Assisted Hatching in the human blastocyst vitrification/warming programme at Drs Aevitas Institute for Reproductive Medicine.
AFRIKAANSE OPSOMMING: Hierdie studie is ontwerp om die gevestigde embrio vitrifikasie/ontdooi program by Drs Aevitas Instituut vir Reproduktiewe Medisyne, retrospektief te evalueer en die faktore te optimaliseer wat swangerskap uitkomste kan beïnvloed. Vitrifikasie is die proses waardeur die molekulere aktiwiteit binne die embrio in ‘n staat van arres gehou word sonder om die strukture binne die sitplasma te versteur. Dit behels die plasing van ʼn embrio in 'n klein hoeveelheid vitrifikasie medium wat teen 'n hoë tempo afgekoel word. Die vitrifikasie medium bevat kriobeskermmiddels wat die embrio tydens die vitrifikasie proses teen moontlike skade beskerm. Hierdie proses is aanvanklik voorgestel om oortollige embrio’s doeltreffend te bestuur. Dit bied ʼn koste effektiewe metode vir embrio terugplasing, en verlaag die insidensie van veelvoudige swangerskap. Vitrifikasie bied pasiënte met ʼn hoë risiko vir ovariale hiperstimulasiesindroom (OHSS) ‘n alternatief om nadelige kliniese simptome te vermy indien ʼn swangerskap bereik word. Tegnologiese vordering en voortdurende navorsing ondersoek voortdurend nuwe tegnieke vitrifikasie uitkomste te optimaliseer. Fokus word geplaas op die draertoestel wat gebruik word vir vitrifikasie, die dag waarop die embrio's gevitrifiseer en gestoor word, sowel as die aantal embrio’s wat met elke vitrifikasie siklus teruggeplaas word. Hierdie retrospektiewe studie het bevestig dat die gebruik van die Cryotop® die mees suksesvolle toestel vir oorlewing en swangerskap uitkomste is. Die terugplasing van dag 5 gevitrifiseerde embrios het beduidende hoër swangerskapsyfers as dag 6 embrios tot gevolg gehad. Die resultate het ook aangedui dat die aantal embrio's wat teruggeplaas word 'n beduidende uitwerking op die swangerskapsyfer het. Daar kan dus moontlik teen die implementering van 'n enkel embrio-terugplasing neiging in die vitrifikasie program geargumenteer word. Resultate het ook getoon dat optimale uitkomste verwant is aan ʼn laer oösiet ouderdom, alhoewel dit nie in die groep pasiente statisties bewys kon word nie. 'n Literatuurstudie oor AH (Assisted Hatching) op gevitrifiseerde/ontdooide menslike embrio’s is uitgevoer om die vitrifikasie/ontdooi program verder te optimaliseer. AH bied ‘n oplossing vir Zona pellucida verharding, wat tydens vitrifikasie plaasvind. Verdere studies, 'n meta-analise van die literatuur, sowel as 'n prospektiewe studie om die effek van laser AH in gevitrifiseerde/ontdooide menslike blastosiste by Drs Aevitas Instituut vir reproduktiewe medisyne te evalueer, word voorgestel.
Hoogendijk, Christiaan F. (Christiaan Frederik). "Sperm DNA fragmentation : implications in assisted reproductive technologies." Thesis, Stellenbosch : Stellenbosch University, 2007. http://hdl.handle.net/10019.1/21626.
Full textENGLISH ABSTRACT: Male fertility has for many years been defined in vitro as the ability of sperm to fertilize oocytes and to obtain early cleavage-stage embryos. Spermatozoa comprise of an extraordinary high percentage of polyunsaturated fatty acids in their plasma membrane. Due to an extremely low content of cytoplasm, sperm cells have a particularly low potential to scavenge reactive oxygen species (ROS), and are therefore highly sensitive to oxidative processes, which lead to sperm nucleus DNA damage/fragmentation. Normally, DNA fragmentation occurs in every ejaculate and can be induced by an excessive ROS production of active leukocytes or the spermatozoa themselves. Under distressed conditions, DNA fragmentation may also occur in the testis as a result of oxidative processes in the apoptotic cascade. These DNA fragmentations can be regarded as late signs of programmed cell death (apoptosis). Clinically, DNA fragmentation in spermatozoa results in significantly decreased implantation and pregnancy rates especially in patients with oligo- and/or teratozoospermia. The p-pattern normal sperm morphology has been shown to give poorer fertilization rates in vitro than the g- and n-patterns. In this study there is reported on the significant correlation found between the p-pattern normal sperm morphology and sperm DNA fragmentation as measured with the terminal deoxynucleotidyl transferase-mediated dUDP-biotin end labeling (TUNEL) assay. This finding further explains the lower fertility potential of patients presenting with p-pattern normal sperm morphology. In addition, this study explores the intricate relations between ROS in the semen, DNA fragmentation of the spermatozoa, as measured with the TUNEL assay and the sperm chromatin structure assay (SCSA ), spermatozoa apoptotic status and sperm parameters as measured with a standard semen analysis. Positive correlations were found between ROS and the apoptotic status of the sperm, as well as between sperm with non-fragmented DNA and sperm concentration and percentage motility. The results emphasize the importance of sperm selection especially when the treatment of choice is intracytoplasmic sperm injection (ICSI). An early sign of programmed cell death, also known as apoptosis, is the externalization of phosphatidylserine (PS) from the inner membrane leaflet to the outer leaflet. PS shows a high affinity to Annexin V. Apoptotic spermatozoa are able to fertilize oocytes, but embryo senescence may occur at the time when the paternal genes are activated. In this study there is reported on a novel method whereby spermatozoa can be separated on the basis of their apoptotic status through flow cytometry. Results showed that the normal sperm morphology, according to strict criteria, of the resultant nonapoptotic sperm fraction is significantly higher than that of the apoptotic counterpart. With refinement of this technique, it will be possible in future to use these separated non-apoptotic sperm cells during ICSI for fertilization. From the above it is apparent that the spermatozoon has to play a vital role in the development of the embryo from fertilization to implantation and pregnancy. It is, however, important to note that besides the gametes, there are other critical factors which contribute to a successful in vitro fertilization (IVF) cycle, among these are the in vitro culture conditions. In this regard, this study compared two sequential embryo culture systems. It was found that the more complex medium resulted in better day three embryo quality and a better blastocyst formation rate and pregnancy rate. These findings highlight the importance of a holistic perspective towards the complexity of the factors involved in affecting embryo quality and pregnancy outcome.
AFRIKAANSE OPSOMMING: Manlike fertiliteit is vir baie jare gedefinieer as die in vitro vermoë van ‘n spermsel om ‘n eiersel te bevrug om sodoende embrios te verkry. Die spermsel se plasmamembraan bestaan uit ‘n hoë persentasie poli-onversadigde vetsure. As gevolg van die klein hoeveelhede sitoplasma van die spermsel het dit ‘n beperkte weerstand teen reaktiewe suurstof spesies (ROS) en is gevolglik baie sensitief vir oksidasie. Oksidasie lei tot DNS skade/fragmentasie. DNS fragmentasie kom in spermselle van alle ejakulate voor en is gewoonlik die gevolg van ROS produksie deur die leukosiete in die semen of vanaf die spermselle self. Onder sekere omstandighede kan DNS fragmentasie ook voorkom in die testis waar dit deel vorm van apoptose. Hierdie tipe DNS skade word gesien as laat tekens van geprogrammeerde seldood (apoptose). In oligo- en/of teratozoospermiese mans lei DNS fragmentasie tot verlaagde implantasie- en swangerskapssyfers. Die p-patroon normale sperm morfologie groep gee laer in vitro bevrugting en swangerskapsyfers as die g- en n-patrone. In hierdie studie doen ons verslag oor die statisties betekenisvolle korrelasie wat gevind is tussen die p-patroon normale sperm morfologie en DNS fragmentasie soos gemeet met die ‘terminal deoxynucleotidyl transferase-mediated dUDP-biotin end labeling’ of te wel TUNEL toets. Hierdie bevinding is ‘n verdere verklaring vir die laer fertiliteits potensiaal van pasiënte wat voordoen met p-patroon sperm morfologie. ‘n Verdere doel van die studie was om die moontlike verband tussen ROS in die semen, spermatozoa DNS fragmentasie, apoptotiese status van die sperms en die motiliteits parameters van die spermatozoa te bepaal. ‘n Positiewe korrelasie is gevind tussen ROS en sperm apoptotiese status. Sperms met ongeframenteerde DNS is ook positief gekorreleer met sperm konsentrasie en motiliteit. Die resultate beklemtoon die belangrikheid van spermseleksie veral in pasiënte waar die keuse van behandeling intrasitoplasmiese sperm inspuiting (ICSI) is. ‘n Vroeë teken van apoptose is die eksternalisering van ‘phosphatidylserine’ (PS) vanaf die interne oppervlakte van die plasmamembraan na die eksterne oppervlak. PS het ‘n hoë affiniteit vir Annexin V. Apoptotiese sperms het die vermoë om ‘n oösiet te bevrug, maar kan lei tot die staking van embrio deling wanneer die vaderlike gene ‘n rol begin speel in embrio ontwikkeling. In hierdie studie het ons ‘n nuwe metode ontwikkel waarvolgens die spermatozoa in die ejakulaat op grond van hul apoptotiese status geskei kan word in apoptotiese en nie-apoptotiese fraksies. Die normale sperm morfologie van die nie-apoptotiese fraksie is betekenisvol beter as dié van die apoptotiese fraksie. Verdere verfyning van die tegniek kan daartoe lei dat dit in die toekoms toegepas kan word om vir nie-apoptotiese sperms te selekteer veral voor die uitvoering van ICSI. Uit die bogenoemde is dit duidelik dat die spermsel ‘n baie belangrike rol in die ontwikkeling van ‘n embrio, vanaf bevrugting tot implantasie en swangerskap, speel. Dit is egter ook belangrik om in gedagte te hou dat daar ander bydraende faktore tot ‘n suksesvolle in vitro swangerskap is, soos laboratorium toestande en embrio kultuursisteem. Om hierdie rede is daar ook twee kultuurmedia in hierdie studie vergelyk. Daar is bevind dat die meer komplekse medium beter kwaliteit embrios op dag drie lewer, asook meer blastosiste en ‘n hoër swangerskapsyfer. Dit is dus duidelik dat dit uiters belangrik is om ‘n holistiese perspektief te hê op die komplekse faktore wat ‘n invloed mag hê op bevrugting, embrio kwaliteit asook die swangerskapsyfer.
Smith, Heather K. "The impact of framing on policy passage: the case of assisted reproductive technology." Thesis, Georgia Institute of Technology, 2011. http://hdl.handle.net/1853/42774.
Full textGoldsmith, Shona. "Population studies of assisted reproductive technology and congenital anomalies in cerebral palsy." Thesis, The University of Sydney, 2019. https://hdl.handle.net/2123/21909.
Full textBooks on the topic "Assisted Reproductive Technology"
P, Marrs Richard, ed. Assisted reproductive technologies. Boston: Blackwell Scientific Publications, 1993.
Find full textGardner, David K., Botros R. M. B. Rizk, and Tommaso Falcone, eds. Human Assisted Reproductive Technology. Cambridge: Cambridge University Press, 2009. http://dx.doi.org/10.1017/cbo9780511734755.
Full textHafez, E. S. E. 1922-, ed. Assisted human reproductive technology. New York: Hemisphere, 1991.
Find full textPregnancy after assisted reproductive technology. Cambridge: Cambridge University Press, 2012.
Find full textJauniaux, Eric, and Botros Rizk, eds. Pregnancy After Assisted Reproductive Technology. Cambridge: Cambridge University Press, 2012. http://dx.doi.org/10.1017/cbo9780511902604.
Full textStevenson, Eleanor L., and Patricia E. Hershberger, eds. Fertility and Assisted Reproductive Technology (ART). New York, NY: Springer Publishing Company, 2016. http://dx.doi.org/10.1891/9780826172549.
Full textCommission, Victorian Law Reform. Assisted reproductive technology & adoption: Final report. Melbourne: Victorian Law Reform Commission, 2007.
Find full textDe, Jonge Christopher J., and Barratt C. L. R, eds. Assisted reproductive technology: Accomplishments and new horizons. Cambridge, UK: Cambridge University Press, 2002.
Find full textK, Gardner David, ed. Textbook of assisted reproductive techniques: Laboratory and clinical perspectives. 2nd ed. London: Taylor & Francis, 2004.
Find full textK, Gardner David, ed. Textbook of assisted reproductive technologies: Laboratory and clinical perspectives. 3rd ed. London: Informa Healthcare, 2009.
Find full textBook chapters on the topic "Assisted Reproductive Technology"
Abrams, David B., J. Rick Turner, Linda C. Baumann, Alyssa Karel, Susan E. Collins, Katie Witkiewitz, Terry Fulmer, et al. "Assisted Reproductive Technology." In Encyclopedia of Behavioral Medicine, 139. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_100120.
Full textVukadinovich, David M., and Susan L. Krinsky. "Assisted Reproductive Technology." In International Library of Ethics, Law, and the New Medicine, 89–111. Dordrecht: Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-015-9674-9_7.
Full textFauser, Bart C. J. M., and Didi D. M. Braat. "Assisted reproductive technology." In Textbook of Obstetrics and Gynaecology, 263–82. Houten: Bohn Stafleu van Loghum, 2019. http://dx.doi.org/10.1007/978-90-368-2131-5_14.
Full textDatta, Sanjay, Bhavani Shankar Kodali, and Scott Segal. "Assisted Reproductive Technology." In Obstetric Anesthesia Handbook, 387–98. New York, NY: Springer New York, 2009. http://dx.doi.org/10.1007/978-0-387-88602-2_18.
Full textMatteo, Maria. "Assisted Reproductive Technology." In Practical Clinical Andrology, 237–50. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-11701-5_18.
Full textten Have, Henk, and Maria do Céu Patrão Neves. "Assisted Reproductive Technology." In Dictionary of Global Bioethics, 137. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-54161-3_65.
Full textPereira, Nigel, and Zev Rosenwaks. "Assisted Reproductive Technology." In Problem-Focused Reproductive Endocrinology and Infertility, 213–21. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-19443-6_30.
Full textPeterson, C. Matthew, Ahmad O. Hammoud, Erika Lindley, Douglas T. Carrell, and Karen Wilson. "Assisted Reproductive Technology Practice Management." In Reproductive Endocrinology and Infertility, 7–37. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-1436-1_2.
Full textBanks, Nicole, and James H. Segars. "Epigenetics and Assisted Reproductive Technology." In Epigenetic Epidemiology, 117–36. Dordrecht: Springer Netherlands, 2011. http://dx.doi.org/10.1007/978-94-007-2495-2_8.
Full textSchenker, Joseph G. "Assisted Reproductive Technology: Artificial Insemination." In Encyclopedia of Global Bioethics, 185–91. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-09483-0_29.
Full textConference papers on the topic "Assisted Reproductive Technology"
de Haan, J., CJM de Groot, A. Bouwman, MB Crijns, ACJ van Akkooi, F. Amant, and CAR Lok. "P99 Recurrent melanoma after pregnancy and assisted reproductive technology." In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.159.
Full textBajkovec, Lucija, Ines Begović, Ana-Marija Đaković, Milan Milošević, Urelija Rodin, and Aida Mujkić. "475 Assisted reproductive technology techniques and risk for neurodevelopmental disorders." In 10th Europaediatrics Congress, Zagreb, Croatia, 7–9 October 2021. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2021. http://dx.doi.org/10.1136/archdischild-2021-europaediatrics.475.
Full textKoseki, Susumu, Kazuhiro Kawamura, Futoshi Inoue, Koji Ikuta, and Masashi Ikeuchi. "Magnetically Controlled Microrobot for Embryo Transfer in Assisted Reproductive Technology." In 2019 20th International Conference on Solid-State Sensors, Actuators and Microsystems & Eurosensors XXXIII (TRANSDUCERS & EUROSENSORS XXXIII). IEEE, 2019. http://dx.doi.org/10.1109/transducers.2019.8808545.
Full textLepore, Mario, and Antonio Petruzziello. "A Situation-Aware DSS to Support Assisted Reproductive Technology Outcome Prediction." In 2021 IEEE Conference on Cognitive and Computational Aspects of Situation Management (CogSIMA). IEEE, 2021. http://dx.doi.org/10.1109/cogsima51574.2021.9475933.
Full textHongQing, Liao, and Ouyang Xinping. "The effect of sperm morphology on the outcome of Assisted Reproductive Technology." In 2014 2nd International Conference on Advances in Social Science, Humanities, and Management. Paris, France: Atlantis Press, 2014. http://dx.doi.org/10.2991/asshm-14.2014.77.
Full textAlekseeva, Liliya L., Ayuna Ts Budatsyrenova, and Marina R. Mangataeva. "Gestation course after the methods of assisted reproductive technology in the Buryat Republic." In Eurasian paradigm of Russia: values, ideas and experience. Buryat State University Publishing Department, 2015. http://dx.doi.org/10.18101/978-5-9793-0814-2-198-200.
Full textPaolanti, Marina, Marco Mameli, Emanuele Frontoni, Giorgia Gioacchini, Elisabetta Giorgini, Valentina Notarstefano, Carlotta Zaca, Oliana Carnevali, and Andrea Borini. "Automatic Classification of Human Granulosa Cells in Assisted Reproductive Technology using vibrational spectroscopy imaging." In 2020 25th International Conference on Pattern Recognition (ICPR). IEEE, 2021. http://dx.doi.org/10.1109/icpr48806.2021.9412544.
Full textSasaki, Hayato, Masaya Nakata, Mizuki Yamamoto, Teppei Takeshima, Yasushi Yumura, and Tomoki Hamagami. "Investigation about Control of False Positive Rate for Automatic Sperm Detection in Assisted Reproductive Technology." In 2018 IEEE International Conference on Systems, Man, and Cybernetics (SMC). IEEE, 2018. http://dx.doi.org/10.1109/smc.2018.00339.
Full textYang, Rui. "Research on Quantitative Methylation Action of PEG1 in Assisted Reproductive Technologies by Network Video Consultation Platform." In 2015 7th International Conference on Information Technology in Medicine and Education (ITME). IEEE, 2015. http://dx.doi.org/10.1109/itme.2015.139.
Full textPuumala, Susan E., Heather H. Nelson, Julie A. Ross, Ruby H. N. Nguyen, Mark A. Damario, and Logan G. Spector. "Abstract 1897: DNA methylation levels in specific imprinting control regions in children conceived with and without assisted reproductive technology (ART)." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-1897.
Full textReports on the topic "Assisted Reproductive Technology"
Leroux, Marie-Louise, Pierre Pestieau, and Gregory Ponthiere. The optimal design of assisted reproductive technologies policies. CIRANO, June 2022. http://dx.doi.org/10.54932/ezmm9028.
Full textWang, Fangfang, Tao Yu, Xiaolu Chen, Rong Luo, and Dezhi Mu. Assisted reproductive technology and the risk of cerebral palsy in the offspring: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2021. http://dx.doi.org/10.37766/inplasy2021.3.0060.
Full text